Core Laboratories N.V.
CLB | NYSE
$8.93
-$0.72 (-7.46%)
At close: Nov 5, 2026, 4:00 PM ET
$8.93
$0.00 (0.00%)
After-hours:
Nov 5, 2026, 4:01 PM ET
TTM Period Ending | Q3 2026 Sep 30, 2026 | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 516.74M | 519.18M | 524.73M | 526.52M | 517.5M | 517.38M | 517.8M | 523.85M | 522.82M | 513.77M | 511.07M | 509.79M | 509.15M | 509.77M | 502.79M | 489.74M | 487.3M | 479.32M | 477.17M | 470.25M | 458.86M | 446.26M | 443.25M |
Cost of Revenue | 425.44M | 425.12M | 431.12M | 432.24M | 428.92M | 430.9M | 430.23M | 435.48M | 427.13M | 417.19M | 410.79M | 407.93M | 410.3M | 412.86M | 410.52M | 406.46M | 399.55M | 389.37M | 385.26M | 372.77M | 374.07M | 367.36M | 369.62M |
Gross Profit | 91.29M | 94.06M | 93.61M | 94.28M | 88.59M | 86.48M | 87.57M | 88.37M | 95.69M | 96.57M | 100.28M | 101.86M | 98.85M | 96.92M | 92.27M | 83.28M | 87.75M | 89.95M | 91.91M | 97.49M | 84.79M | 78.9M | 73.63M |
Operating Income | 39.11M | 48.04M | 54.18M | 56.71M | 54.81M | 53.69M | 54.4M | 58.56M | 58.96M | 53.83M | 56.73M | 54.64M | 55.68M | 55.65M | 48.4M | 41.52M | 40.11M | 32.1M | 33.25M | 45.26M | 54.47M | 59.16M | 43.79M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 27.8M | 36.8M | 43.08M | 45.9M | 44.22M | 42.64M | 42.85M | 46.19M | 45.61M | 40.44M | 43.31M | 41.21M | 42.78M | 42.77M | 36.04M | 29.95M | 29.03M | 21.49M | 22.82M | 36.11M | 44.56M | 47.25M | 31.04M |
Net Income | 15.56M | 24.35M | 29.03M | 29.67M | 32.12M | 29.63M | 28.03M | 31.4M | 26.2M | 23.71M | 37.52M | 36.68M | 41.23M | 39.49M | 23.71M | 19.45M | 15.39M | 8.74M | 9.73M | 19.73M | 30.58M | 32.67M | 18.89M |
Selling & General & Admin | 46.37M | 45.79M | 45.3M | 44.23M | 43.88M | 41.52M | 41.31M | 39.46M | 38.67M | 39.46M | 34.68M | 39.22M | 39.65M | 40.54M | 41.77M | 41.31M | 43.44M | 48.48M | 51.36M | 43.95M | 38.29M | 32.19M | 31.81M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 5.82M | 234K | -5.87M | -6.65M | -10.1M | -8.73M | -8.15M | -9.64M | -1.94M | 3.29M | 8.87M | 8M | 3.52M | 730K | 2.11M | 442K | 4.2M | 9.37M | 7.3M | 8.28M | -7.96M | -12.44M | -1.97M |
Operating Expenses | 52.19M | 46.02M | 39.43M | 37.57M | 33.78M | 32.79M | 33.16M | 29.82M | 36.73M | 42.74M | 43.55M | 47.22M | 43.17M | 41.27M | 43.88M | 41.76M | 47.64M | 57.85M | 58.67M | 52.22M | 30.32M | 19.75M | 29.84M |
Interest Expense | 11.13M | 11M | 10.86M | 10.57M | 10.59M | 11.05M | 11.55M | 12.37M | 13.36M | 13.4M | 13.42M | 13.43M | 12.89M | 12.88M | 12.36M | 11.57M | 11.08M | 10.61M | 10.43M | 9.15M | 9.48M | 11.49M | 12.32M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 290K | -83K | -419K | -749K | -1.04M | -666K | -330K | -136K | -136K | -210K | -287K | -228K | -228K | 1.35M | 1.43M | 1.5M |
Cost & Expenses | 477.63M | 471.14M | 470.55M | 469.81M | 462.69M | 463.69M | 463.39M | 465.29M | 463.86M | 459.94M | 454.34M | 455.15M | 453.47M | 454.12M | 454.4M | 448.21M | 447.2M | 447.22M | 443.92M | 424.99M | 404.4M | 387.1M | 399.46M |
Income Tax Expense | 12.17M | 12.1M | 13.51M | 15.51M | 11.49M | 12.42M | 14.12M | 14.03M | 18.49M | 16.1M | 5.23M | 4.19M | 1.5M | 3.05M | 12.1M | 10.3M | 13.27M | 12.38M | 12.64M | 15.89M | 13.61M | 14.31M | 11.99M |
Shares Outstanding (Basic) | 46.71M | 46.88M | 46.07M | 46.5M | 47.08M | 47.51M | 46.77M | 46.83M | 46.92M | 46.91M | 46.86M | 46.86M | 46.69M | 46.68M | 46.63M | 46.36M | 46.34M | 46.32M | 46.3M | 46.35M | 46.29M | 46.32M | 45.18M |
Shares Outstanding (Diluted) | 46.71M | 46.88M | 46.07M | 46.5M | 47.08M | 47.51M | 46.77M | 47.77M | 47.82M | 47.74M | 47.7M | 47.56M | 47.6M | 47.5M | 47.48M | 46.83M | 47.01M | 47.14M | 46.3M | 46.93M | 47.13M | 47.1M | 45.96M |
EPS (Basic) | 0.34 | 0.52 | 0.61 | 0.63 | 0.68 | 0.63 | 0.60 | 0.67 | 0.55 | 0.50 | 0.80 | 0.79 | 0.89 | 0.85 | 0.51 | 0.42 | 0.33 | 0.19 | 0.21 | 0.43 | 0.67 | 0.72 | 0.42 |
EPS (Diluted) | 0.34 | 0.52 | 0.61 | 0.63 | 0.68 | 0.63 | 0.60 | 0.67 | 0.56 | 0.50 | 0.79 | 0.77 | 0.86 | 0.83 | 0.50 | 0.41 | 0.33 | 0.19 | 0.21 | 0.43 | 0.67 | 0.72 | 0.42 |
EBITDA | 53.9M | 62.65M | 68.63M | 71.12M | 69.46M | 68.41M | 69.23M | 73.51M | 74.44M | 69.57M | 72.05M | 70.16M | 71.08M | 71.3M | 66.17M | 59.81M | 57.61M | 48.98M | 47.93M | 60.26M | 61.28M | 67.59M | 54.36M |
EBIT | 38.86M | 47.8M | 53.94M | 56.47M | 54.81M | 53.69M | 54.4M | 58.56M | 59.28M | 54.15M | 56.47M | 54.38M | 55.1M | 55.07M | 49.52M | 42.65M | 40.13M | 31.17M | 29.73M | 41.74M | 42.33M | 47.97M | 34.06M |
Depreciation & Amortization | 14.98M | 14.85M | 14.7M | 14.65M | 14.65M | 14.73M | 14.83M | 14.95M | 15.16M | 15.42M | 15.58M | 15.78M | 15.98M | 16.23M | 16.65M | 17.16M | 17.49M | 17.81M | 18.2M | 18.52M | 18.96M | 19.62M | 20.3M |
Add to Watchlist
Select watchlists to add or remove CLB